CarrieOakleyDoughertyMDFAHS

Neurology • Washington, DC

Headache

Associate Professor of Neurology, Program Director Headache Fellowship

Join to view full profile

Dr. Dougherty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dougherty's full profile

Already have an account?

Office
3800 Reservoir Road NW
Washington, DC 20007

Summary

Dr. Carrie Dougherty is a neurologist based in Mc Lean, VA, specializing in headache disorders. She completed her internship in Internal Medicine at McGaw Medical Center, Northwestern University, and residency in Neurology at MedStar Health/Georgetown University Hospital. She has in-depth experience in headache medicine, botulinum toxin injections for headache and has substantial contributions to the field through her publications in reputable journals, chiefly in 'Headache' and 'Current Pain and Headache Reports'. Topics of her research include evaluation of vascular risk in migraine patients, Raynaud's phenomenon, dermatologic symptoms associated with headache, and medication dosage reviews for migraine prevention.

Education & Training

MedStar Health/Georgetown University HospitalResidency, Neurology, 2009 - 2012
McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2008 - 2009
Indiana University School of MedicineClass of 2008

Certifications & Licensure

VA State Medical License 2012 - 2026
DC State Medical License 2009 - 2024
MD State Medical License 2012 - 2024
PA State Medical License 2012 - 2014
IL State Medical License 2008 - 2009
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

The 2024 Scottsdale Headache Symposium: A banner year.
Deborah I Friedman, Carrie Dougherty, Scott W Powers
Headache. 2024-10-17
7 citations
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
David Kudrow, Rima Dafer, David W Dodick, Amaal Starling, Jessica Ailani
Headache. 2023-03-01
6 citations
Raynaud's phenomenon associated with calcitonin gene-related peptide receptor antagonists case report.
Kate Bedrin, Jessica Ailani, Carrie Dougherty
Headache. 2022-11-01

Press Mentions

Updated STOP 301 Results Demonstrate Safety, Tolerability of INP104 for MigraineJune 4th, 2021
Impel Neuropharma to Present Pivotal, Phase 3 Data from STOP-301 Study at the 63rd Annual Meeting of the American Headache SocietyJune 2nd, 2021
Migraine World Summit Premieres Online March 17th - 25th, 2021February 8th, 2021
Join now to see all